The protooncogene c-fos has been implicated in the control of proliferation and transformation of fibroblasts, and its protein product is an essential component of transcription factor AP1. The important target genes and, hence, the molecular mechanism of Fos function are, however, still unknown, partly due to the lack of a tightly regulated Fos-induction system. Here we show that different activities of the Fos protein can be controlled hormonally by fusing the mouse c-Fos protein to the ligand-binding domain of either the rat glucocorticoid or the human estrogen receptor. These fusion proteins stimulate AP1-dependent transcription and repress endogenous fos mRNA synthesis in a strictly hormonedependent manner. Expression ofthese chimeric proteins in rat fibroblasts results in fast, reversible, and tightly controlled transformation in response to hormone. A Fos-estrogen receptor expressing cell line was used to isolate Fos-responsive genes by subtractive cDNA cloning. Run-on analysis of one of these genes showed that its transcription is rapidly and directly regulated by the hormone-activated Fos-estrogen receptor protein, demonstrating the potential of this induction system for identifying Fos target genes.
The protooncogene c-fos is thought to play a central role in signal transduction by coupling short-term stimulation of the cell to long-term alterations in gene expression. c-fos codes for a nuclear protein that is an important component of transcription factor AP1. In the AP1 complex the Fos protein is bound to the product of another protooncogene, c-jun, via a specific leucine zipper interaction. Fos-Jun heterodimers bind AP1 sites with high affinity in contrast to Jun homodimers and, as a consequence, efficiently stimulate AP1-dependent transcription (1) (2) (3) (4) (5) . The Fos protein also can repress the transcription of some immediate early genes, including its own gene (5) (6) (7) . This activity of Fos requires intact C-terminal sequences, whereas the DNA-binding domain of Fos is dispensable (6) (7) (8) . The main target of Fosmediated repression is the serum response element rather than the AP1-binding site (7) (8) (9) . Deregulated expression of the c-fos gene transforms fibroblasts (10) , which correlates with the ability of c-Fos to transactivate rather than to repress gene transcription (8) .
The detailed structure-function analysis of the Fos transcription factor is in clear contrast to our present ignorance about the relevant Fos target genes involved in control of cell proliferation and transformation. Identification of such target genes would be greatly facilitated by the availability of a selective and tightly regulated Fos-induction system. Recently, the activity of certain proteins was shown to be brought under hormonal control by fusing them to the ligandbinding domain of steroid receptors (11, 12) . Here we demonstrate that the transactivating, repressing, and transforming activities of c-Fos can be subjected to strict hormonedependent regulation in Fos-steroid receptor fusion proteins. The potential of this induction system is illustrated by differential cDNA cloning of genes that are regulated by Fos in rat fibroblasts.
MATERIALS AND METHODS
Construction offos Fusion Genes. The expression vector pX was derived from the plasmids CDM8 (13) and Bluescript (Stratagene); its transcription unit consists of the cytomegalovirus enhancer/promoter, the Bluescript polylinker, the simian virus 40 small tumor antigen intron, and a polyadenylylation site. Plasmid pX-cFos contains the mouse c-fos gene as a 1324 base-pair (bp) Acc I fragment of the cDNA clone pGEMfos3 (3) in the EcoRV site of pX. pX-FosER was generated by inserting a BamHI-Sac I fragment of plasmid HE14 containing the hormone-binding domain of the human estrogen receptor (ER) (14) into the Sac I site of pX-cFos. pX-FosGR was obtained by linking the same Sac I site of pX-cFos to a Bgl II site introduced 5' of codon 512 of the rat glucocorticoid receptor (GR) gene (P. J. Godowski, personal communication). Retroviral constructs pMV-cFos, pMVFosER, and pMV-FosGR were generated by cloning the c-fos, fos-ER gene, and fos-GR gene as EcoRI-HindIII fragments into pMV-7 (15) . pSV-FosER was constructed by inserting the 970-bp Sac I fragment of pX-FosER into the Sac I site of pSV-Fos (5).
Chloramphenicol Acetyltransferase (CAT) Assays. The transactivator expression plasmid (2 ,kg), the CAT reporter gene (1 ,ug), the S-galactosidase plasmid pCH110 (2 ,ug, Pharmacia), and pSP64 DNA (5 ,ug) were transfected into cells by the calcium phosphate coprecipitation method. Thirty-six hours later the cells were harvested, and protein extracts were separately analyzed for j8-galactosidase and CAT activity as described (16 S1 Nuclease, Northern (RNA) Blot, and Run-On Analysis. Fifteen to 30 ug of cytoplasmic RNA was used for S1 nuclease or Northern blot analysis, as described (19, 20) . Nuclei of estrogen-treated and untreated FR 3T3 cells expressing the Fos-ER protein were isolated and nascent RNA transcripts were labeled with [a-32P]UTP (3000 Ci/mmol; 1 Ci = 37 GBq) as described (21) .
Subtractive cDNA Cloning and Differential cDNA Hybridization. cDNA was synthesized from poly(A)+ RNA of estrogen-stimulated cells, was subtracted by hybridization from poly(A)+ RNA of untreated cells, and was cloned into AgtlO DNA as described (22) . Replica filters were hybridized with radiolabeled cDNA probes as described (22) . (Fig. 2) Fig. 3C shows that the endogenous c-fos gene was equally well repressed under all these conditions, indicating that estrogen very rapidly activates the repression function of the Fos-ER protein. In a second experiment, estrogen, serum, and the protein synthesis inhibitor cycloheximide were added at the same time to serum-starved cells (Fig. 3B) . Cycloheximide is known to affect fos gene expression at two different levels. It prevents transcriptional shut-off and leads to mRNA stabilization due to the block of synthesis of endogenous Fos and of a labile mRNA-destabilizing protein. The prediction for the cycloheximide experiment, therefore, is that the c-fos promoter should be repressed only in those cell lines containing preexisting exogenous Fos activity. Fig. 3B shows that a 5-fold, cycloheximide-insensitive repression is, indeed, seen in the Fos-ER-expressing cell line with, but not without, estrogen. In summary we have shown that the Fos-ER protein is rapidly activated by estrogen and that it directly represses the endogenous c-fos promoter.
RESULTS

Fos
Hormone-Dependent Transformation by Fos-Steroid Receptor Fusion Proteins. The transforming potential of the chimeric Fos proteins was analyzed in Rat-lA cells by three different criteria: focus formation, morphological transformation, and growth in soft agar (Fig. 4) . The focus-formation assay was carried out by infecting Rat-lA cells with retroviruses either lacking or containing one of the threefos genes shown in Fig. 1 . No foci were obtained with the parental vector pMV-7 (Fig. 4A) . Neither hormone had any effect on the number of foci generated by infection with pMV-cFos. In contrast, over a 100-fold increase in focus number was seen with the two chimeric fos genes (pMV-FosGR and pMVFosER) in the presence of the appropriate hormone.
G418-resistant cell lines containing the fos-ER gene were established either by infection with the retrovirus pMVFosER or by cotransfection of plasmid pSV-FosER with a neomycin-resistance gene. Cell lines obtained by either method gave identical results in the morphology test and soft-agar-colony assay. In the absence of estrogen, the cells are flat, contact-inhibited, and indistinguishable from parental Rat-lA cells (Fig. 4B) addition, the cells round up, elongate, and start to display a transformed morphology, which, after a few days, is identical with that of Fos-transformed Rat-lA cells. Moreover, transformation by Fos-ER is completely reversible, as cells incubated with estrogen for >2 weeks return to normal morphology within 2 days when reseeded in estrogen-free medium (data not shown). Fig. 4C shows the behavior of a Fos-ER cell line in the soft-agar-colony assay. These cells grow to large colonies with estrogen, whereas their growth is inhibited to the same extent as that of the parental Rat-lA cells without hormone. Some Fos-ER cell lines were derived from soft agar colonies grown with estrogen for 3 weeks. These cell lines exhibited an untransformed phenotype in estrogen-free medium and, if retested, grew in soft agar only with hormone. This further demonstrates that hormone-dependent transformation by Fos-ER is tightly regulated and that continuous Fos activity is required for maintaining the transformed phenotype. We therefore conclude that Fos-steroid receptor fusion proteins induce reversible hormone-dependent transformation of Rat-lA fibroblasts as defined by three different criteria.
Isolation of Fos-Responsive Genes by Subtractive cDNA Cloning. By S1 nuclease analysis we could not detect any endogenous ER mRNA in two rat fibroblast cell lines, Rat-lA and FR 3T3, confirming our observation that estrogen is an inert signal for these cells (Fig. 4 and G.S.-F., unpublished data). As a consequence, estrogen very specifically activates the exogenous Fos-ER protein in our stable cell lines, which leads to reprogramming of gene expression as manifested by the observed phenotypic changes in response to hormone. Fos-ER-expressing cell lines should, therefore, be useful for the identification of Fos-regulated genes by subtractive cDNA cloning techniques. IG. 6 . Direct transcriptional activation of the Fit-1 gene by Fos-ER. Fos-ER-expressing FR 3T3 cells were exposed to estrogen (1 ,uM) for the indicated time before nuclei preparation and labeling of nascent RNA by run-on transcription. The different RNA probes were hybridized to immobilized cDNA of the Fit-1, rat gapdh, and mouse actin genes as well as to pSP64 DNA. Where indicated, a-amanitin (2 gg/ml; a-am.) was added to the nuclei before labeling of nascent transcripts.
900-bp-long cDNA inserts that hybridized to estrogeninduced transcripts. For further analysis we have chosen one of these cDNA clones, which we refer to as Fos-induced transcript I or Fit-1 gene.
Rapid Transcriptional Activation of the Fit-1 Gene by Fos-ER. The Fit-1 cDNA probe detects a mRNA of -2600 nucleotides (Fig. 5A ). In the Fos-ER-expressing FR 3T3 cells Fit-1 mRNA increases -10-fold in response to estrogen, reaching a level identical to that of the Fos-transformed FR 3T3 cell line. The Fit-1 mRNA level is, however, very low in the parental FR 3T3 cells, even after 24-hr treatment with estrogen. This fact clearly indicates that expression of the Fit-1 gene is regulated by the exogenous Fos protein rather than by an endogenous estrogen-induced activity.
The kinetics of Fit-1 mRNA synthesis in response to estrogen was studied in Fos-ER-expressing FR 3T3 and Rat-iA cells (Fig. S B and C) (11, 12) . All three induction systems take advantage of a general "protein inactivation" function that is part of the ligand-binding domain of steroid receptors and which, in the absence of hormone, can repress other activities present on the same polypeptide chain (11, 24) . It has been postulated that the interaction of the abundant heat shock protein hsp90 with the unliganded hormone-binding domain may cause this repression function (11) . In agreement, recent in vivo experiments have shown an important role of hsp90 in signal transduction by steroid receptors (25) . well as a nuclear localization signal in the case of the GR (for review, see ref. 26) . Grafting these functions onto the Fos protein might, therefore, modify Fos activity in the fusion protein. However, so far we have not seen any significant qualitative or quantitative differences between Fos and Fossteroid receptor fusion proteins in transactivation, repression, and transformation assays.
The c-Fos protein stimulates AP1-dependent transcription by binding to AP1 recognition sequences as part of a heterodimeric complex with Jun proteins (1) (2) (3) (4) (5) . Transcriptional activation by Fos-steroid receptor fusion proteins also depends on AP1-binding sites and is lowest in F9 cell, where the endogenous Jun levels are very low (Fig. 2) . Furthermore, in vitro-translated Fos-ER protein can bind to AP1 sites only in the presence of Jun protein (G.S.-F. and M.B., unpublished data). All this evidence indicates that Fos-steroid receptor fusion proteins also require complex formation with Jun proteins for transcriptional activity. The activated GR has recently been shown to repress AP1 activity (27) , and yet our Fos-GR fusion protein stimulates AP1-dependent transcription (Fig. 2) , suggesting that the hormone-binding domain alone is not sufficient to interfere with AP1 activity.
Transcriptional shut-off of the c-fos promoter depends on new protein synthesis, and the c-fos gene product itself is thought to act as a repressor by interfering with activity of the serum response element (5-9). It is, however, still unclear whether Fos is directly involved in repression by interacting with factors binding to the serum response element element or whether it affects expression of another nuclear protein that then controls c-fos transcription. To address this question, we have taken advantage of stable rat fibroblast cell lines that constitutively express Fos-ER protein. This exogenous protein can repress serum-induced transcription from endogenous c-fos promoter in a hormone-dependent manner (Fig. 3) . Its repression function is immediately activated upon hormone addition and does not require ongoing protein synthesis, indicating that the Fos protein plays a direct role in down-regulation of its own promoter.
Hormone-dependent transformation of rat fibroblasts by the Fos-ER protein is fast and reversible, indicating that continuous Fos activity is required for maintaining the transformed phenotype. Most importantly, transformation is tightly controlled by estrogen. In this context it is relevant to note that the ER used in this study contains an amino acid substitution in the hormone-binding domain (Gly-400 -> Val), which reduces the affinity for estrogen and, hence, conveniently prevents activation by trace amounts of hormone (28) . Thus, estrogen does not morphologically transform Fos-ER cell lines at 0.1 nM. However, 1 nM estrogen results in slow transformation after a week, whereas fast transformation within a day is observed at concentrations of 10 nM and above (data not shown). Transcriptional activation of estrogen-responsive genes by the mutant ER (HEO) is maximal between 1 nM and 0.1 nM estrogen (28) 
